These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization of Growth Hormone Resistance in Experimental and Ulcerative Colitis. Soendergaard C; Kvist PH; Thygesen P; Reslow M; Nielsen OH; Kopchick JJ; Holm TL Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946616 [TBL] [Abstract][Full Text] [Related]
3. Fundamental mechanisms of growth failure in inflammatory bowel disease. Ballinger A Horm Res; 2002; 58 Suppl 1():7-10. PubMed ID: 12373006 [TBL] [Abstract][Full Text] [Related]
4. Growth hormone and the insulin-like growth factor system in myogenesis. Florini JR; Ewton DZ; Coolican SA Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory Diseases and Growth: Effects on the GH-IGF Axis and on Growth Plate. Cirillo F; Lazzeroni P; Sartori C; Street ME Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858208 [TBL] [Abstract][Full Text] [Related]
6. Recent advances in the biochemistry and physiology of the insulin-like growth factor/somatomedin family. Herington AC; Cornell HJ; Kuffer AD Int J Biochem; 1983; 15(10):1201-10. PubMed ID: 6313443 [TBL] [Abstract][Full Text] [Related]
7. The anabolic effects of GH/IGF system on bone. Kasukawa Y; Miyakoshi N; Mohan S Curr Pharm Des; 2004; 10(21):2577-92. PubMed ID: 15320746 [TBL] [Abstract][Full Text] [Related]
8. Growth hormone reduces the severity of fibrosis associated with chronic intestinal inflammation. Theiss AL; Fuller CR; Simmons JG; Liu B; Sartor RB; Lund PK Gastroenterology; 2005 Jul; 129(1):204-19. PubMed ID: 16012948 [TBL] [Abstract][Full Text] [Related]
9. Modulation of the growth hormone-insulin-like growth factor (GH-IGF) axis by pharmaceutical, nutraceutical and environmental xenobiotics: an emerging role for xenobiotic-metabolizing enzymes and the transcription factors regulating their expression. A review. Scarth JP Xenobiotica; 2006; 36(2-3):119-218. PubMed ID: 16702112 [TBL] [Abstract][Full Text] [Related]
10. Bidirectional Regulation of Circadian Disturbance and Inflammation in Inflammatory Bowel Disease. Liu X; Yu R; Zhu L; Hou X; Zou K Inflamm Bowel Dis; 2017 Oct; 23(10):1741-1751. PubMed ID: 28902123 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory Bowel Disease in a Rodent Model Alters Osteocyte Protein Levels Controlling Bone Turnover. Metzger CE; Narayanan A; Zawieja DC; Bloomfield SA J Bone Miner Res; 2017 Apr; 32(4):802-813. PubMed ID: 27796050 [TBL] [Abstract][Full Text] [Related]
12. Growth hormone, the insulin-like growth factor system, and the kidney. Feld S; Hirschberg R Endocr Rev; 1996 Oct; 17(5):423-80. PubMed ID: 8897021 [TBL] [Abstract][Full Text] [Related]
13. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease. Toogood AA; Jones J; O'Neill PA; Thorner MO; Shalet SM Clin Endocrinol (Oxf); 1998 May; 48(5):569-76. PubMed ID: 9666868 [TBL] [Abstract][Full Text] [Related]
14. Survival and cellular immune functions in septic mice treated with growth hormone (GH) and insulin-like growth factor-I (IGF-I). Schmitz D; Kobbe P; Lendemanns S; Wilsenack K; Exton M; Schedlowski M; Oberbeck R Growth Horm IGF Res; 2008 Jun; 18(3):245-52. PubMed ID: 18023601 [TBL] [Abstract][Full Text] [Related]
15. Involvement of growth hormone (GH) and insulin-like growth factor (IGF) system in ovarian folliculogenesis. Silva JR; Figueiredo JR; van den Hurk R Theriogenology; 2009 May; 71(8):1193-208. PubMed ID: 19193432 [TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells. Fruchtman S; Simmons JG; Michaylira CZ; Miller ME; Greenhalgh CJ; Ney DM; Lund PK Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G342-50. PubMed ID: 15831713 [TBL] [Abstract][Full Text] [Related]
17. Nutritional regulation of the insulin-like growth factors. Thissen JP; Ketelslegers JM; Underwood LE Endocr Rev; 1994 Feb; 15(1):80-101. PubMed ID: 8156941 [TBL] [Abstract][Full Text] [Related]
18. Expression of insulin-like growth factor-I in transgenic mice. D'Ercole AJ Ann N Y Acad Sci; 1993 Aug; 692():149-60. PubMed ID: 8215019 [TBL] [Abstract][Full Text] [Related]
19. Is insulin-like growth factor 1 (IGF-1) system an attractive target inflammatory bowel diseases? Benefits and limitation of potential therapy. Zatorski H; Marynowski M; Fichna J Pharmacol Rep; 2016 Aug; 68(4):809-15. PubMed ID: 27117379 [TBL] [Abstract][Full Text] [Related]
20. Manipulation of the Growth Hormone-Insulin-Like Growth Factor (GH-IGF) Axis: A Treatment Strategy to Reverse the Effects of Early Life Developmental Programming. Reynolds CM; Perry JK; Vickers MH Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28786951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]